MASIMO CORP — Director's Dealing 2020

Dec 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MASIMO CORP (MASI)
CIK: 0000937556
Period of Report: 2020-12-15

Reporting Person: Sampath Anand (EVP, Ops & Clinical Research)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-15	Common Stock	M	15000	$31.01	Acquired	28782	Direct
2020-12-15	Common Stock	S	15000	$265.6103	Disposed	13782	Direct
2020-12-15	Common Stock	M	15000	$21.77	Acquired	28782	Direct
2020-12-15	Common Stock	S	15000	$265.5767	Disposed	13782	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-15	Non-Qualified Stock Option (Right to Buy)	$31.01	M	15000	Disposed	2025-03-20	Common Stock (15000.0)	Direct
2020-12-15	Non-Qualified Stock Option (Right to Buy)	$21.77	M	15000	Disposed	2024-08-12	Common Stock (15000.0)	Direct

Footnotes

F1: The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of November 11, 2020, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.

F2: The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $262.41 per share to a high of $267.77 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $262.03 per share to a high of $267.68 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This option was granted on March 20, 2015 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.

F5: This option was granted on August 12, 2014 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.